1.Development of monoclonal antibodies against the abnormal prion protein isoform (PrPres) associated with chronic wasting disease (CWD).
Hyun Jeong JEONG ; Nak Hyung LEE ; Joong Bok LEE ; Seung Yong PARK ; Chang Seon SONG ; Kun Ho SEO ; Dong Woon KIM ; Yong Sun KIM ; In Soo CHOI
Journal of Veterinary Science 2012;13(4):429-432
Monoclonal antibodies (mAbs) specific for the abnormal prion protein isoform (PrPres) are indispensable for diagnosing chronic wasting disease (CWD). In this study, eight mAbs were developed by immunizing PrP knockout mice with recombinant elk PrP and an immunogenic PrP peptide. The reactivity of the mAbs to recombinant PrP and the PrP peptide was measured, and their isotypes were subsequently determined. Among them, four mAbs (B85-05, B85-08, B85-12, and B77-75) were shown by Western blotting to recognize proteinase K-treated brain homogenate derived from an elk suffering from CWD.
Animals
;
Antibodies, Monoclonal
;
Blotting, Western
;
Brain
;
Mice
;
Mice, Knockout
;
Stress, Psychological
;
Wasting Disease, Chronic
2.Pathological characterization of TgElk mice injected with brain homogenate from elk with chronic wasting disease.
Yong Chul JEON ; Jin Kyu CHOI ; Eun Kyung CHOI ; Richard I CARP ; Yong Sun KIM
Journal of Veterinary Science 2013;14(1):21-26
Chronic wasting disease (CWD) is classified as a transmissible spongiform encephalopathy or prion disease that affects cervids. CWD has been reported in 15 US states, two Canadian provinces, and in imported elk on several farms in Korea. This study was conducted to examine the molecular biological and pathogenic characteristics of a CWD-associated prion isolated in Korea. The epidemiological origin of this pathogen was also determined. Homozygous TgElk mice were infected with a CWD-affected elk brain pool prepared from the brain of an imported Canadian elk. We measured the incubation time of the pathogen, neuropathological changes by immunohistochemical staining, the pattern(s) of scrapie prion protein (PrPSc) deposition, and PrPSc protein profiles by Western blotting. We found that TgElk mice infected with brain homogenate from the elk suffering from CWD showed incubation times, vacuolar degeneration, and PrPSc accumulation similar to those previously reported in the literature. Our results suggest that homozygous TgElk mice efficiently transmit CWD with short incubation times and that this animal can serve a valuable research model and reliable in vivo diagnostic tool.
Animals
;
Brain/*pathology
;
*Deer
;
Female
;
Genotype
;
Mice
;
Mice, Transgenic
;
Prions
;
Republic of Korea/epidemiology
;
Wasting Disease, Chronic/epidemiology/*pathology/transmission
3.Pathological characterization of TgElk mice injected with brain homogenate from elk with chronic wasting disease.
Yong Chul JEON ; Jin Kyu CHOI ; Eun Kyung CHOI ; Richard I CARP ; Yong Sun KIM
Journal of Veterinary Science 2013;14(1):21-26
Chronic wasting disease (CWD) is classified as a transmissible spongiform encephalopathy or prion disease that affects cervids. CWD has been reported in 15 US states, two Canadian provinces, and in imported elk on several farms in Korea. This study was conducted to examine the molecular biological and pathogenic characteristics of a CWD-associated prion isolated in Korea. The epidemiological origin of this pathogen was also determined. Homozygous TgElk mice were infected with a CWD-affected elk brain pool prepared from the brain of an imported Canadian elk. We measured the incubation time of the pathogen, neuropathological changes by immunohistochemical staining, the pattern(s) of scrapie prion protein (PrPSc) deposition, and PrPSc protein profiles by Western blotting. We found that TgElk mice infected with brain homogenate from the elk suffering from CWD showed incubation times, vacuolar degeneration, and PrPSc accumulation similar to those previously reported in the literature. Our results suggest that homozygous TgElk mice efficiently transmit CWD with short incubation times and that this animal can serve a valuable research model and reliable in vivo diagnostic tool.
Animals
;
Brain/*pathology
;
*Deer
;
Female
;
Genotype
;
Mice
;
Mice, Transgenic
;
Prions
;
Republic of Korea/epidemiology
;
Wasting Disease, Chronic/epidemiology/*pathology/transmission
4.Correlation between Frailty Level and Disability of the Elderly and Frailty Related Factors.
Seung Hyun MA ; Ki Yun JEUNG ; Sun Hyoung HONG ; Eun Young SHIM ; Sang Ho YOO ; Mee Young KIM ; Jong Lull YOON
Korean Journal of Family Medicine 2009;30(8):588-597
BACKGROUND: Frailty is a wasting syndrome that presents loss of physiological function by aging, lowering of reserve capacity, and disability of body system. It is currently being considered an important issue in geriatrics. This study examined frailty level of Korean elderly in community and whether frailty can be meaningful a predictive factor for functional disability. METHODS: Demographic characteristics, the number of chronic diseases and medications, cardiovascular health study (CHS) frailty index, study of osteoporotic fractures (SOF) frailty index, activities of daily living, Instrumental activities of daily living, depression, mini-mental state examination (MMSE) and fall history were examined for 302 men and women over 65 years old who visited the three community seniors welfare centers from February 2008 to June 2008. RESULTS: There were definite differences of frailty status by age, educational level, marital status, monthly income, body mass index, the number of chronic diseases, the number of medications, depression, MMSE and fall history (P < 0.05), except in gender (P < 0.432). In logistic regression analysis for functional disability with frailty status defined by SOF frailty index, odds ratio to dependency of instrumental activities of daily living (IADL) from the healthy to the prefrail stage increased 6.84 times while from the healthy to the frail stage increased 130.87 times. These effects still increased after covariate adjustment. Also, the CHS frailty index showed the same result although there was some difference in odds ratio. CONCLUSION: There were meaningful correlations of frailty with functional disability when dividing Korean elderly's frailty levels into the healthy, the prefrail and the frail stages.
Activities of Daily Living
;
Aged
;
Aging
;
Body Mass Index
;
Chronic Disease
;
Dependency (Psychology)
;
Depression
;
Female
;
Geriatrics
;
Humans
;
Logistic Models
;
Male
;
Marital Status
;
Odds Ratio
;
Osteoporotic Fractures
;
Wasting Syndrome
5.The Study for the Relationship of Weight Loss with Plasma Leptin and TNF-alpha Level in Patients with Chronic Bronchitis and Emphysema.
Jong Hae PACK ; Ji Young PARK ; Hye Jeong PARK ; Suk Hwan BAEK ; Kyeong Cheol SHIN ; Jin Hong CHUNG ; Kwan Ho LEE
Tuberculosis and Respiratory Diseases 2003;54(2):199-209
BACKGROUND: Unexplained weight loss, which commonly occurs in patients with chronic obstructive pulmonary disease(COPD), is important because weight loss is an independent risk factor of mortality and morbidity in these patients. Leptin is known to play an important role in regulating body weight. In addition, the tumor necrosis factor(TNF-α) might also play a potential role in the weight loss experienced in chronic wasting disease. The aim of this study was to determine the influence of plasma leptin and the circulating TNF-α system to the difference in the body compositions in patients with COPD. METHODS: Spirometry, body composition analysis and the plasma concentrations of leptin, TNF-α and a soluble TNF receptor 55, 75 were measured in 31 patients with chronic bronchitis and 10 patients with emphysema. The COPD subtype was classified by the transfer coefficient of carbon monoxide, DLco/VA. RESULTS: The circulating levels of leptin were significantly lower in those patients with emphysema(108.5±39.37 pg/ml) than those with chronic bronchitis(180.9±57.7 pg/ml). The circulating levels of sTNF-R55 were significantly higher in the emphysema patients(920.4±116.4 pg/ml) than in those with chronic bronchitis(803.2±80.8 pg/ml). There was no relationship between the circulating leptin levels and the activated TNF system in patients with chronic bronchitis and emphysema. However, the circulating leptin levels correlated well with the BMI and fat mass in both patient groups. CONCLUSION: These results suggest that the weight loss noted in emphysema patients may be associated with the activation of the TNF-α system rather than the plasma leptin level.
Body Composition
;
Body Weight
;
Bronchitis, Chronic*
;
Carbon Monoxide
;
Emphysema*
;
Humans
;
Leptin*
;
Mortality
;
Necrosis
;
Plasma*
;
Pulmonary Disease, Chronic Obstructive
;
Receptors, Tumor Necrosis Factor
;
Risk Factors
;
Spirometry
;
Tumor Necrosis Factor-alpha*
;
Wasting Disease, Chronic
;
Weight Loss*
6.Serum adiponectin level and cardiovascular disease in patients with end-stage renal disease.
Hui Young LEE ; Ae Young HER ; Dong Wook CHOI ; Myoung Ok PARK ; Hyun Jeong BAEK ; Hae Hyuk JUNG
Korean Journal of Medicine 2006;71(6):646-653
BACKGROUND: Adiponectin is a fat-based protein that alters the insulin sensitivity, has anti-inflammatory properties, and reduces the incidence of cardiovascular disease (CVD). However, this connection is unclear in patients with chronic wasting disease, such as heart failure or end-stage renal disease (ESRD). Therefore, this study examined the relationship between adiponectin and the cardiovascular risk/predictive factors in ESRD patients. METHODS: The serum concentrations of adiponectin and leptin were measured in 48 adult patients on maintenance hemodialysis. In addition, the blood levels of B-type natriuretic peptide (BNP) and cardiac troponin T (cTnT) as cardiovascular biomarkers were measured, and the CVD history was reviewed in order to determine if there was any correlation with adiponectin. RESULTS: There was a significant correlation between the adiponectin levels and the serum concentrations of HDL-cholesterol (r=0.456, p=0.001), triglyceride (r=-0.528, p<0.001), and leptin (r=-0.427, p=0.002) and an inverse correlation with the body mass index (BMI) (r=-0.326, p=0.024). The BNP levels were positively correlated with the adiponectin concentrations (r=0.372, p=0.009) and negatively correlated with the BMI (r=-0.310, p=0.032), and there was a slight positive correlation between cTnT and adiponectin (r=0.276, p=0.058). Patients with a history of CVD had higher levels of cTnT (p=0.012) and BNP (p=0.017), and a lower BMI (p=0.026) than patients without such a history. There was no significant difference in the adiponectin levels between the two patient groups. CONCLUSIONS: A higher adiponectin level is related to a favorable lipid profile. However, adiponectin is not directly associated with a history of CVD, and there was a correlation between a higher adiponectin level and a higher BNP and lower BMI, which are cardiovascular predictive factors, in ESRD patients. However, further research with more patients will be needed to properly determine the complicated relationship between adiponectin and the development of CVD.
Adiponectin*
;
Adult
;
Biomarkers
;
Body Mass Index
;
Cardiovascular Diseases*
;
Heart Failure
;
Humans
;
Incidence
;
Insulin Resistance
;
Kidney Failure, Chronic*
;
Leptin
;
Natriuretic Peptide, Brain
;
Renal Dialysis
;
Triglycerides
;
Troponin T
;
Wasting Disease, Chronic